Cardiology Research

Cardiac Diagnostic Test

Cardiac Diagnostic test It is the process to understand the complexity of disease, injury and abnormalities. The rising demand for efficient and rapid diagnostics of cardiovascular diseases, Cardiac Biomarker Testing is leading the market and expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period. Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. The other diagnostic tests that are being used to further understand and identify cardiovascular disease are:

• 
  Electrocardiogram


• 
  Echocardiogram


• 
  Coronary Arteriogram


• 
  Positron Emission Tomography


• 
  Thallium Scans or Myocardial Perfusion Scans


• 
  Electrophysiology Study


• 
  Cardiac Catheterization


• 
  Troponin-blood test

Troponin blood tests are widely used to help physicians detect heart attacks, test looks at a protein that comes directly from the heart and is found at elevated levels in the blood after heart muscle has been injured. As healthcare systems make a shift from treating symptoms of heart disease to preventing the onset of it, research now indicates that measuring a person's troponin levels using Abbott's High Sensitive Troponin-I blood test also can help predict a person's chances of having a cardiac event potentially years in advance when they show no signs or symptoms.

• 
  Electrocardiogram


• 
  Stress test


• 
  Transthoracic echocardiogram


• 
  Positron emission tomography (PET) scan


• 
  Thallium scans or myocardial perfusion scans


• 
  Holter monitor


• 
  Electrophysiology study


• 
  MRI of the heart


• 
  Cardiac CT scan